• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

NPJ Vaccines . Muscle macrophage regenerative response after squalene-adjuvanted influenza vaccination is associated with type II-skewed response an

tetano

Editor, Senior Moderator
NPJ Vaccines


. 2026 Jul 4.
doi: 10.1038/s41541-026-01436-6. Online ahead of print.
Muscle macrophage regenerative response after squalene-adjuvanted influenza vaccination is associated with type II-skewed response and is reduced with age

Moataz Noureddine[SUP] 1 2 3 [/SUP], Lauren A Chang[SUP] 1 2 3 [/SUP], Farah El Ayache[SUP] 1 2 [/SUP], Gabriel Laghlali[SUP] 1 2 4 [/SUP], Eleanor Burgess[SUP] 1 2 3 [/SUP], Leonie Gruneberg[SUP] 1 2 [/SUP], Prajakta Warang[SUP] 1 2 [/SUP], Kaijun Jiang[SUP] 1 2 3 [/SUP], Johanna Vandekerckhove[SUP] 1 2 5 [/SUP], Vivian Yan[SUP] 1 2 3 [/SUP], Haye Nijhuis[SUP] 5 [/SUP], Lynda Coughlan[SUP] 6 7 [/SUP], Bruno G De Geest[SUP] 4 [/SUP], Juan Garcia-Bernalt Diego[SUP] 1 2 [/SUP], Seok-Chan Park[SUP] 1 2 [/SUP], Jorge Levican[SUP] 1 2 [/SUP], Michael Schotsaert[SUP] 8 9 10 11 [/SUP]


Affiliations
Free article Abstract

Squalene-based adjuvants like MF59 and AddaVax induce transient muscle injury, but their downstream mechanisms remain unclear. We show that intramuscular injection of a quadrivalent inactivated influenza vaccine (QIV) with AddaVax triggers a muscle regenerative-like immune response, increasing CX3CR1⁺Ly6C⁺ macrophages in muscle and draining lymph nodes within four days. This promotes a type II-skewed immune response, with elevated IgG1 titers and Th2 cytokines in the lungs after influenza challenge. In aged mice, the macrophage response and type II skewing are diminished. Adoptive transfer of young mice bone marrow-derived macrophages into aged mice at vaccination leads to macrophage antigen uptake, lymph node migration, and type II immune bias. However, this restoration does not improve protection against mismatched viral challenge, suggesting additional age-related immune impairments. These findings highlight the role of macrophage-driven muscle regeneration in adjuvant activity and underscore the need to better understand how muscle damage and repair influence intramuscular vaccine efficacy.


 
Back
Top